{"log_id": 3650769613521270690, "direction": 0, "words_result_num": 38, "words_result": [{"probability": {"variance": 0.015192, "average": 0.94325, "min": 0.398571}, "location": {"width": 1049, "top": 308, "height": 75, "left": 331}, "words": "这些改变通常是轻微、一过性的并不需要中断治疗。在接受本品治疗的患者中具有临床意"}, {"probability": {"variance": 0.022199, "average": 0.918215, "min": 0.437294}, "location": {"width": 1047, "top": 358, "height": 77, "left": 331}, "words": "义的血清转氨酶升高(正常上限3倍)的发生率为0.8%、所有者发生的这改变均与剂"}, {"probability": {"variance": 0.027, "average": 0.898304, "min": 0.479503}, "location": {"width": 297, "top": 411, "height": 48, "left": 329}, "words": "量相关并且都是可逆性的"}, {"probability": {"variance": 0.007729, "average": 0.947479, "min": 0.702087}, "location": {"width": 994, "top": 466, "height": 77, "left": 379}, "words": "与其它临床试验中的 hmg-coa还原酶抑制剂相似,服用本品的患者中有2.5%的病人"}, {"probability": {"variance": 0.027874, "average": 0.888697, "min": 0.413608}, "location": {"width": 1042, "top": 518, "height": 75, "left": 326}, "words": "山现血清磁酸肌酸激酶(CPK升高大于正常上限3倍服月本品的患者中有0.4%的病人共"}, {"probability": {"variance": 0.049053, "average": 0.85414, "min": 0.390782}, "location": {"width": 445, "top": 571, "height": 52, "left": 322}, "words": "磷酸肌酸激升高大于正上限10倍"}, {"probability": {"variance": 0.012673, "average": 0.952732, "min": 0.497268}, "location": {"width": 992, "top": 624, "height": 75, "left": 377}, "words": "他汀类药品的上市后监测中有高血糖反应,量异常、糖化它红蛋白水平升高、新发"}, {"probability": {"variance": 0.017356, "average": 0.940403, "min": 0.35674}, "location": {"width": 825, "top": 676, "height": 66, "left": 317}, "words": "慧尿病、血糖控制恶化的报:部分他汀类药品亦有低血糖反应的报告"}, {"probability": {"variance": 0.008717, "average": 0.960251, "min": 0.503958}, "location": {"width": 989, "top": 729, "height": 75, "left": 372}, "words": "上市后经验:他汀类药品的国外上市后监测中有罕见的认知障碍的报道,表魂为记忆力"}, {"probability": {"variance": 0.013661, "average": 0.945685, "min": 0.539095}, "location": {"width": 955, "top": 779, "height": 73, "left": 313}, "words": "丧失、记忆力卜降、思维淮孔等:多为非严重、可逆性反应,一般停药后即可复"}, {"probability": {"variance": 0.050555, "average": 0.713626, "min": 0.411417}, "location": {"width": 91, "top": 834, "height": 34, "left": 324}, "words": "【禁"}, {"probability": {"variance": 0.010941, "average": 0.947121, "min": 0.680579}, "location": {"width": 242, "top": 887, "height": 45, "left": 361}, "words": "本品禁用丁以下者"}, {"probability": {"variance": 0.017624, "average": 0.921131, "min": 0.599197}, "location": {"width": 320, "top": 941, "height": 45, "left": 379}, "words": "对木品所含任何成份过敏者"}, {"probability": {"variance": 0.010251, "average": 0.955836, "min": 0.498018}, "location": {"width": 880, "top": 992, "height": 66, "left": 386}, "words": "活动性肝病患者、血清转氨酶水平持续升高超过正常上限3倍且原因不明"}, {"probability": {"variance": 7e-06, "average": 0.996751, "min": 0.994019}, "location": {"width": 57, "top": 1047, "height": 32, "left": 386}, "words": "肌病"}, {"probability": {"variance": 0.019736, "average": 0.924578, "min": 0.408276}, "location": {"width": 967, "top": 1095, "height": 73, "left": 384}, "words": "孕期、哺来及任何未采取适当避学措的育龄妇女用本品(见【学妇及哺乳期"}, {"probability": {"variance": 0.001495, "average": 0.964843, "min": 0.904044}, "location": {"width": 141, "top": 1147, "height": 34, "left": 294}, "words": "妇女用药〗"}, {"probability": {"variance": 0.065277, "average": 0.836178, "min": 0.394849}, "location": {"width": 134, "top": 1200, "height": 34, "left": 320}, "words": "注意事"}, {"probability": {"variance": 0.011653, "average": 0.929866, "min": 0.7431}, "location": {"width": 112, "top": 1252, "height": 34, "left": 349}, "words": "肝脏影响"}, {"probability": {"variance": 0.0268, "average": 0.911271, "min": 0.38651}, "location": {"width": 996, "top": 1303, "height": 73, "left": 345}, "words": "开始治疗前应做肝功检查并定期复查患者出现何提示有肝脏的症状或件征时应"}, {"probability": {"variance": 0.014494, "average": 0.932337, "min": 0.479005}, "location": {"width": 1051, "top": 1351, "height": 77, "left": 288}, "words": "检查肝功能。转复酶水平升高的患者应加以监测直至恢复正常。如果转氨酶持续升高超过正"}, {"probability": {"variance": 0.002532, "average": 0.963867, "min": 0.872837}, "location": {"width": 644, "top": 1406, "height": 57, "left": 285}, "words": "常3倍以上,建议减量或用本品(见【不良反应"}, {"probability": {"variance": 0.046818, "average": 0.861967, "min": 0.384115}, "location": {"width": 470, "top": 1458, "height": 54, "left": 329}, "words": "过量饮和/或有脏病史患者慎用品"}, {"probability": {"variance": 0.025121, "average": 0.902128, "min": 0.447395}, "location": {"width": 599, "top": 1511, "height": 59, "left": 331}, "words": "强化降低胆固醇水平预防卒中发生( SPARCL研究"}, {"probability": {"variance": 0.037231, "average": 0.852103, "min": 0.357037}, "location": {"width": 1015, "top": 1559, "height": 82, "left": 326}, "words": "在一项事后分析中,在无冠心病(CHD>的近期有卒中或短暂缺血发作联"}, {"probability": {"variance": 0.000262, "average": 0.97843, "min": 0.962235}, "location": {"width": 38, "top": 1591, "height": 38, "left": 1534}, "words": "20"}, {"probability": {"variance": 0.020149, "average": 0.912669, "min": 0.464597}, "location": {"width": 1085, "top": 1609, "height": 77, "left": 276}, "words": "卒中亚型进行了分析,与安慰剂较,阿托他汀80m吃治疗组患者出血性率中发生率较备修"}, {"probability": {"variance": 0.035573, "average": 0.86993, "min": 0.383749}, "location": {"width": 1051, "top": 1664, "height": 77, "left": 274}, "words": "在研究入选时有出直卒中或腔隙性梗塞史的患考中危险性的增加显著,于江消出虚"}, {"probability": {"variance": 0.016304, "average": 0.944336, "min": 0.386463}, "location": {"width": 1051, "top": 1717, "height": 75, "left": 272}, "words": "性邓中的患者,阿托伐他汀80mg治疗的风与获益的平衡尚不确定,在开始治疗前,应"}, {"probability": {"variance": 0.016714, "average": 0.951313, "min": 0.508084}, "location": {"width": 347, "top": 1771, "height": 48, "left": 272}, "words": "细考忘出血性卒中的潜在危险"}, {"probability": {"variance": 0.009412, "average": 0.934141, "min": 0.744294}, "location": {"width": 139, "top": 1829, "height": 34, "left": 315}, "words": "骨骼肌影响"}, {"probability": {"variance": 0, "average": 0.696415, "min": 0.696415}, "location": {"width": 281, "top": 1829, "height": 70, "left": 1175}, "words": " A9HARMACEUTICAZ"}, {"probability": {"variance": 0.002612, "average": 0.953225, "min": 0.87049}, "location": {"width": 148, "top": 1870, "height": 48, "left": 1246}, "words": "(中国)"}, {"probability": {"variance": 0.041024, "average": 0.878712, "min": 0.398362}, "location": {"width": 1001, "top": 1874, "height": 77, "left": 313}, "words": "与其他 hmg-coa矫原抑制剂一样:在罕见情况下,阿托伐他汀可能影响骨L,引"}, {"probability": {"variance": 0, "average": 0.809898, "min": 0.809898}, "location": {"width": 34, "top": 1895, "height": 34, "left": 1390}, "words": "非"}, {"probability": {"variance": 0.033124, "average": 0.85996, "min": 0.402825}, "location": {"width": 1131, "top": 1925, "height": 84, "left": 262}, "words": "痛、肌炎和肌病,可能进为威励兰命的横纹溶解症,现为CPK明显计高超公司"}, {"probability": {"variance": 0.015647, "average": 0.941662, "min": 0.513642}, "location": {"width": 720, "top": 1979, "height": 61, "left": 267}, "words": "正常上限10倍以上)、球蛋白血症和肌球蛋白尿,导致肾"}, {"probability": {"variance": 0.001455, "average": 0.971378, "min": 0.917446}, "location": {"width": 86, "top": 2037, "height": 34, "left": 260}, "words": "治疗前"}], "language": 3}